Stock

U.S. bans imports of certain Apple Watches that may infringe on patented pulse readers

The U.S. has officially banned imports of certain Apple Watch models after the Biden administration declined to veto an agency’s decision to restrict the products.

The affected watches come with a pulse oximeter feature that reads blood-oxygen levels. Apple has included the feature in every watch since its 2020 Series 6 model.

At issue is a complaint by the California-based medical monitoring technology company Masimo that the pulse reader feature infringes on its pulse-oximeter technology, which is designed to monitor blood oxygen levels.

In October, the U.S. International Trade Commission ruled that the Apple products must be excluded from the U.S. marketplace based on evidence of infringement. That decision, which went into effect Tuesday, would have needed a presidential veto to be overturned.

Apple ended direct U.S. sales of affected Ultra 2 and Series 9 watches last week.

In a statement, Apple said it is appealing the trade commission decision, though it already rejected a request to pause the ban during the appeals process. Apple is also suing Masimo.

The Apple Watch SE will continue to be sold directly by Apple.

This post appeared first on NBC NEWS

You May Also Like

Latest News

The presidents of Spain’s regional soccer federations are calling for the resignation of Luis Rubiales, the suspended president of the National Football Association, in...

Latest News

Luis Rubiales on Sunday resigned from his position as president of the Spanish soccer federation following weeks of fierce criticism over his unwanted kiss...

Editor's Pick

When searching for world-class gold deposits, mining companies prefer high-grade, near-surface mineralization. Epithermal gold deposits check these boxes and more. While gold is often...

Editor's Pick

Overview A lot can change in two years — just look at Brazil. Best described as a bit player in the lithium space only...

Disclaimer: dividendsgrowth.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 dividendsgrowth.com